Northern Trust’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-38,679
| Closed | -$784K | – | 4667 |
|
|
2022
Q4 | $784K | Sell |
38,679
-245
| -0.6% | -$3.76K | ﹤0.01% | 3349 |
|
|
2022
Q3 | $418K | Buy |
38,924
+1,498
| +4% | +$17K | ﹤0.01% | 3574 |
|
|
2022
Q2 | $449K | Buy |
37,426
+348
| +0.9% | +$5.61K | ﹤0.01% | 3574 |
|
|
2022
Q1 | $794K | Sell |
37,078
-772
| -2% | -$20.4K | ﹤0.01% | 3538 |
|
|
2021
Q4 | $1.27M | Sell |
37,850
-48
| -0.1% | -$1.34K | ﹤0.01% | 3445 |
|
|
2021
Q3 | $976K | Sell |
37,898
-60
| -0.2% | -$1.07K | ﹤0.01% | 3565 |
|
|
2021
Q2 | $507K | Buy |
37,958
+5,668
| +18% | +$70.1K | ﹤0.01% | 3702 |
|
|
2021
Q1 | $343K | Sell |
32,290
-19,344
| -37% | -$221K | ﹤0.01% | 3934 |
|
|
2020
Q4 | $415K | Sell |
51,634
-8,097
| -14% | -$63.7K | ﹤0.01% | 3769 |
|
|
2020
Q3 | $447K | Buy |
59,731
+2,348
| +4% | +$20.8K | ﹤0.01% | 3644 |
|
|
2020
Q2 | $519K | Buy |
57,383
+10,303
| +22% | +$107K | ﹤0.01% | 3545 |
|
|
2020
Q1 | $451K | Buy |
47,080
+475
| +1% | +$5.69K | ﹤0.01% | 3484 |
|
|
2019
Q4 | $671K | Buy |
46,605
+3,640
| +8% | +$53.1K | ﹤0.01% | 3501 |
|
|
2019
Q3 | $647K | Hold |
42,965
| – | – | ﹤0.01% | 3496 |
|
|
2019
Q2 | $569K | Hold |
42,965
| – | – | ﹤0.01% | 3525 |
|
|
2019
Q1 | $564K | Buy |
42,965
+1,162
| +3% | +$16.9K | ﹤0.01% | 3512 |
|
|
2018
Q4 | $604K | Buy |
41,803
+1,398
| +3% | +$22.8K | ﹤0.01% | 3512 |
|
|
2018
Q3 | $722K | Buy |
40,405
+16,033
| +66% | +$278K | ﹤0.01% | 3554 |
|
|
2018
Q2 | $350K | Buy |
+24,372
| New | +$429K | ﹤0.01% | 3692 |
|
Northern Trust's OPNT Position: Q1 2023 in Review
Northern Trust sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 38,679 shares — an estimated $784K sold.
Northern Trust first reported a position in OPNT in Q2 2018 and held it in 19 quarters. The position peaked at $1.27M in Q4 2021. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.
- Northern Trust reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Northern Trust sold 38,679 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $784K.
- Northern Trust first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 19 quarters.
- Northern Trust's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $1.27M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.
Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.